 Limitations evaluation therapy inflammatory bowel disease suggestions future research current treatment inflammatory bowel disease IBD therapies variable consistent supportive similar management ulcerative colitis UC Crohn disease CD related disorders therapy nonspecific variation therapeutic practices results fact etiologies diseases obscure limited knowledge biological pharmacological actions drugs sulfasalazine compounds steroids azathioprine inadequate understanding genetic differences drug metabolism insufficient awareness factors drug efficiency concurrent use antimotility drugs cigarette smoking food combinations variability patient groups extent severity disease incomplete documentation clinical status patients time therapeutic trial Future advances treatment new information nature IBD drug pharmacology bioavailability collaborative studies clinicians clinical investigators basic scientists Important areas IBD research biology intestinal epithelium nature IBD inflammatory reaction gut mucosal immune regulation application new biotechnologies representative experimental animal models Decisive multicenter therapeutic studies agreement definitions ulcerative colitis Crohn disease accurate characterization patient groups acceptable objective criteria IBD severity activity reliable indicators therapeutic response